Results 191 to 200 of about 25,223 (248)

Shifts in structural connectome organization in the limbic and sensory systems of patients with episodic migraine. [PDF]

J Headache Pain
Noh E, Namgung JY, Park Y, Jang Y, Lee MJ, Park BY.   +5 more
europepmc   +1 more source

Healthcare Utilization, Costs, and Treatment Discontinuation in Adults with Episodic Migraine Initiating Galcanezumab Versus Rimegepant: A US Retrospective Claims Analysis. [PDF]

Adv Ther
Kim G, Hoyt M, Zakharyan A, Durica J, Wallem A, Viktrup L.   +5 more
europepmc   +1 more source

Predictors of Response to Treatment With Anti-calcitonin Gene-Related Peptide (CGRP) Antibodies in Real-World Patients With Episodic Migraine: A Two- and Four-Month Prospective Study. [PDF]

Cureus
Krymchantowski A, Jevoux C, Silva-Néto RP, Soares AA, Pimentel MLV, Krymchantowski AG, Júnior HMDS, Cotrik EM.   +7 more
europepmc   +1 more source

Analysis of the ocular surface functional unit in episodic migraine. [PDF]

Graefes Arch Clin Exp Ophthalmol
Patzkó Á, Csutak A, Tóth N, Kölkedi Z, Pfund Z, Kis-Jakab G, Bosnyák E, Rozgonyi R, Szalai E.   +8 more
europepmc   +1 more source

Feasibility of a 12-Week, Therapist-Independent, Smartphone-Based Biofeedback Treatment for Episodic Migraine in Adults: Single-Center, Open-Label, 1-Armed Trial.

JMIR Hum Factors
Poole AC, Winnberg IG, Simpson MR, Stubberud A, Vetvik KG, Bjørk MH, Øie LR, Holmboe P, Olsen A, Tronvik E, Wergeland T.   +10 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Erenumab for episodic migraine

Pain Management, 2022
In this review, the authors provide an overview of erenumab, a monoclonal antibody used for the preventative treatment of episodic migraine by targeting the CGRP pathway. Randomized controlled trials have shown that erenumab is associated with a statistically significant decrease in monthly migraine days in patients with episodic migraine at monthly ...
Abhigyan Datta, Sahil Gupta, Shashi Maryala, Vikram Aggarwal, Pooja Chopra, Sameer Jain   +5 more
openaire   +2 more sources

Episodic Migraine and POTS

Current Pain and Headache Reports, 2023
Migraine is prevalent in patients with postural orthostatic tachycardia syndrome (POTS). The purpose of this review is to summarize and interpret studies that examine stress response systems in patients with migraine, focusing on their relevance to the pathologies associated with POTS.
openaire   +2 more sources

Episodic daily migraine or episodic status migrainosus

Cephalalgia, 2018
Objective To report a case series of a novel migraine subtype, which we term as episodic status migrainosus (ESM), characterized by attacks of migraine exclusively lasting more than 72 hours. We hypothesized that this would represent a novel nosologic entity, possibly an unstable migraine phenotype with a high conversion rate to chronic migraine (CM ...
Tarun D, Singh, F Michael, Cutrer, Jonathan H, Smith   +2 more
openaire   +4 more sources

Hemiplegic migraine episode triggered by regadenoson

Journal of Nuclear Cardiology, 2022
SPECT and PET myocardial perfusion imaging (MPI) are widely used to evaluate patients for coronary artery disease. Regadenoson (a selective A2A adenosine receptor agonist) is a commonly used vasodilator agent for stress MPI because of its safety profile and ease of use. Common adverse reactions such as headache, shortness of breath, flushing, and chest
Mohammed, Elsadany, Sean R, McMahon, Sandhya, Mehla, W Lane, Duvall   +3 more
openaire   +2 more sources